Northwest Biotherapeutics Inc (NWBO)
0.4659
+0.01
(+1.29%)
USD |
OTCM |
May 02, 16:19
Northwest Biotherapeutics Cash from Financing (Quarterly): 14.42M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 14.42M |
| September 30, 2023 | 17.12M |
| June 30, 2023 | 8.638M |
| March 31, 2023 | 12.58M |
| December 31, 2022 | 11.35M |
| September 30, 2022 | 16.29M |
| June 30, 2022 | 10.41M |
| March 31, 2022 | 3.92M |
| December 31, 2021 | 23.67M |
| September 30, 2021 | 8.92M |
| June 30, 2021 | 4.781M |
| March 31, 2021 | 10.76M |
| December 31, 2020 | 15.82M |
| September 30, 2020 | 16.68M |
| June 30, 2020 | 13.17M |
| March 31, 2020 | 7.025M |
| December 31, 2019 | 5.134M |
| September 30, 2019 | 0.85M |
| June 30, 2019 | 0.029M |
| March 31, 2019 | 3.939M |
| December 31, 2018 | -10.82M |
| September 30, 2018 | 2.065M |
| June 30, 2018 | 9.865M |
| March 31, 2018 | 6.762M |
| December 31, 2017 | 14.30M |
| Date | Value |
|---|---|
| September 30, 2017 | 8.096M |
| June 30, 2017 | 3.851M |
| March 31, 2017 | 8.048M |
| December 31, 2016 | 17.49M |
| September 30, 2016 | 7.682M |
| June 30, 2016 | 3.894M |
| March 31, 2016 | 9.244M |
| December 31, 2015 | 41.37M |
| September 30, 2015 | 0.864M |
| June 30, 2015 | 43.20M |
| March 31, 2015 | 8.51M |
| December 31, 2014 | 41.98M |
| September 30, 2014 | 22.58M |
| June 30, 2014 | 16.98M |
| March 31, 2014 | 4.29M |
| December 31, 2013 | 25.69M |
| September 30, 2013 | 13.34M |
| June 30, 2013 | 9.821M |
| March 31, 2013 | 0.101M |
| December 31, 2012 | 15.48M |
| September 30, 2012 | 5.816M |
| June 30, 2012 | 5.253M |
| March 31, 2012 | 3.594M |
| December 31, 2011 | 2.907M |
| September 30, 2011 | 0.001M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
0.029M
Minimum
Jun 2019
23.67M
Maximum
Dec 2021
10.61M
Average
10.76M
Median
Mar 2021
Cash from Financing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.026M |
| Palatin Technologies Inc | 4.974M |
| iBio Inc | 4.005M |
| Theriva Biologics Inc | -1.457M |
| Oragenics Inc | -0.1806M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -16.96M |
| Cash from Investing (Quarterly) | -0.418M |
| Free Cash Flow | -57.07M |
| Free Cash Flow Per Share (Quarterly) | -0.015 |
| Free Cash Flow to Equity (Quarterly) | -25.23M |
| Free Cash Flow Yield | -10.95% |